Shenzhen Xinhao Photoelectricity Technology (301051)
Search documents
信濠光电:截至2025年9月30日公司股东总数为11955户
Zheng Quan Ri Bao· 2025-12-08 12:13
(文章来源:证券日报) 证券日报网讯 12月8日,信濠光电在互动平台回答投资者提问时表示,截至2025年9月30日,公司股东 总数为11955户。 ...
信濠光电(301051) - 关于提前归还暂时补充流动资金的闲置募集资金的公告
2025-12-02 09:18
证券代码:301051 证券简称:信濠光电 公告编号:2025-094 深圳市信濠光电科技股份有限公司 关于提前归还暂时补充流动资金的闲置募集资金的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 深圳市信濠光电科技股份有限公司(以下简称"公司")于2025年4月17日 召开第三届董事会第十九次会议及第三届监事会第十九次会议,审议通过了《关 于使用部分闲置募集资金暂时补充流动资金的议案》,同意公司在不影响募投项 目建设资金需求和募投项目正常进行的前提下,使用不超过人民币20,000万元 (含本数)的闲置募集资金暂时补充流动资金,使用期限自第三届董事会第十九 次会议审议通过之日起不超过12个月(即使用期限不超过2026年4月16日),到 期前将归还至募集资金专用账户。具体内容详见公司于2025年4月21日在巨潮资 讯网(www.cninfo.com.cn)上披露的《关于使用部分闲置募集资金暂时补充流 动资金的公告》(公告编号:2025-029)。 截至2025年12月2日,公司实际使用7,188.59万元(含手续费)闲置募集资金 暂时补充流动资金。在使用闲置 ...
2025年三季度消费电子市场持续回暖,触控显示上市公司业绩整体向好
CINNO Research· 2025-11-24 23:51
Core Insights - The article highlights a continued recovery in the consumer electronics market during Q3 2025, with overall positive performance from listed companies in the touch display sector [2]. Group 1: Global Shipment Trends - The report provides an analysis of global shipment trends for smartphones and laptops from Q1 2023 to Q3 2025, indicating a general upward trajectory in demand for these devices [3]. Group 2: Revenue and Profit Comparison - A comparative analysis of revenue and operating profit for listed companies in the touch display industry during Q3 2025 is presented, showcasing overall growth in financial performance [3]. Group 3: Company-Specific Trends - Longxin Technology's revenue and operating profit trends, along with its main business composition, are detailed, reflecting its market position [3]. - Lianchuang Electronics' revenue and operating profit trends, as well as its main business structure, are analyzed, indicating its performance in the sector [3]. - Yicheng Optoelectronics' revenue and operating profit trends, along with its main business composition, are discussed, highlighting its operational efficiency [3]. - Chanhong Technology's revenue and operating profit trends, as well as its main business structure, are examined, showing its growth trajectory [3]. - Laibo Gaoke's revenue and operating profit trends, along with its main business composition, are presented, indicating its market competitiveness [3]. - Landai Technology's revenue and operating profit trends, as well as its main business structure, are analyzed, reflecting its performance in the industry [3]. - Lens Technology's revenue and operating profit trends, along with its main business composition, are discussed, showcasing its operational success [3]. - Xinhai Optoelectronics' revenue and operating profit trends, as well as its main business structure, are examined, indicating its market standing [3]. - Helitai's revenue and operating profit trends, along with its main business composition, are presented, reflecting its growth in the sector [3]. - Star Technology's revenue and operating profit trends, as well as its main business structure, are analyzed, highlighting its performance in the market [3].
中国疫苗行业协会倡议:严禁以低于成本的报价参与竞标;海正药业控股子公司拟投建宠物处方粮项目丨医药早参
Mei Ri Jing Ji Xin Wen· 2025-11-19 23:19
Group 1 - The China Vaccine Industry Association has issued an initiative to prohibit bidding below cost, aiming to combat "involution" competition and ensure product and service quality standards in the vaccine industry [1] - The initiative is expected to improve the industry ecosystem and create a fair and orderly competitive environment [1] Group 2 - Bailitianheng has signed a strategic cooperation agreement with the Bank of China Sichuan Branch, which promises to provide comprehensive credit support of no less than 8 billion RMB over five years [2] - This large credit line is expected to alleviate the company's short-term financial pressure from high R&D expenditures and reflects the financial institution's recognition of its industry position and business prospects [2] Group 3 - Haizheng Pharmaceutical's subsidiary plans to invest 100 million RMB in a pet prescription food project, aiming for an annual production capacity of 10,000 tons upon reaching full capacity [3] - The company's diversification strategy includes investments in pet nutrition and synthetic biology, though the conversion to revenue growth remains to be seen [3] Group 4 - Saintno Biological has received a marketing approval notification for the raw material drug Weipena peptide, which is used to treat type 2 diabetes and obesity [4] - This approval reflects the company's comprehensive strength in R&D, production, and quality management, positively impacting its business development [4] - The approval comes amid the expansion of the GLP-1 market, indicating a positive outlook for the company's future growth [4]
信濠光电:持股5%以上股东梁国豪1.32%股份将被司法拍卖
Di Yi Cai Jing· 2025-11-18 11:11
信濠光电晚间公告,持股5%以上股东梁国豪先生所持有的267.15万股(占公司总股本比例1.32%)将被 司法拍卖。梁国豪先生不是公司的第一大股东或其一致行动人,本次司法拍卖不会导致公司第一大股东 发生变化,不会对公司正常生产经营、公司治理产生不利影响。本次司法拍卖事项存在不确定性,公司 将密切关注后续进展并及时履行信息披露义务。 ...
信濠光电(301051) - 关于持股5%以上股东部分股份司法拍卖的进展公告
2025-11-18 10:58
关于持股5%以上股东部分股份司法拍卖的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 深圳市信濠光电科技股份有限公司(以下简称"公司")于 2025 年 11 月 3 日在巨潮资讯网披露了《关于持股 5%以上股东部分股份拟被第二次司法拍卖 的公告》,公司持股 5%以上股东梁国豪先生持有的 3,276,000 股公司股份,于 2025 年 11 月 17 日 10 时至 2025 年 11 月 18 日 10 时止(延时除外)在广东省深 圳市宝安区人民法院淘宝网司法拍卖网络平台进行第二次司法拍卖。 一、司法拍卖的进展情况 经查询,根据淘宝网司法拍卖网络平台公示的《网络竞价成功确认书》, 梁国豪先生持有的 3,276,000 股公司股份拍卖结果如下: | 股东名称 | 拍卖股份数量 | 成交金额 | 占梁国豪先生 | 占公司总 | 竞买人 | 竞买号 | | --- | --- | --- | --- | --- | --- | --- | | | (股) | (人民币元) | 所持股份比例 | 股本比例 | | | | 梁国豪 | 3,276,000 ...
信濠光电(301051) - 关于持股5%以上股东部分股份拟被司法拍卖的公告
2025-11-18 10:58
证券代码:301051 证券简称:信濠光电 公告编号:2025-092 深圳市信濠光电科技股份有限公司 关于持股5%以上股东部分股份拟被司法拍卖的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 特别提示: 1、持有本公司股份19,679,261股(占本公司总股本比例9.69%)的大股东梁 国豪先生所持有的本公司2,671,498股(占本公司总股本比例1.32%)将被广东省 深圳市宝安区人民法院司法拍卖; 2、本公司无控股股东、实际控制人,梁国豪先生不是本公司的第一大股东 或其一致行动人,梁国豪先生本次所持有的部分本公司股份被司法拍卖不会导 致本公司第一大股东发生变化,不会对本公司的正常生产经营、公司治理产生 不利影响; 3、本次司法拍卖事项存在一定的不确定性,公司将密切关注该事项的后续 进展情况并及时履行信息披露义务。敬请广大投资者理性投资,注意投资风险。 深圳市信濠光电科技股份有限公司(以下简称"公司")近日收到广东省 深圳市宝安区人民法院拍卖通知书【(2025)粤0306执恢7196号】通知,获悉 公司股东梁国豪先生持有的2,671,498股公司股份 ...
信濠光电(301051) - 关于持股5%以上股东部分股份被司法划转完成、权益变动触及1%整数倍暨股份解除质押、冻结的公告
2025-11-12 12:38
证券代码:301051 证券简称:信濠光电 公告编号:2025-091 深圳市信濠光电科技股份有限公司 关于持股5%以上股东部分股份被司法划转完成、权益变动 触及1%整数倍暨股份解除质押、冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 深圳市信濠光电科技股份有限公司(以下简称"公司"或"信濠光电") 近日收到股东梁国豪先生的通知,获悉梁国豪先生持有的917,280股公司股份已 被司法划转并完成过户登记手续,具体事项如下: 一、本次司法划转股份情况 根据申请执行人陈海斌与被执行人梁国豪民间借贷纠纷一案的裁定结果, 梁国豪先生持有的 917,280 股公司股份被深圳市宝安区人民法院依法首位冻结, 后移交深圳市龙岗区人民法院依法处分。 2025 年 8 月 20 日公司收到广东省深圳市龙岗区人民法院网拍告知书 【(2025)粤 0307 执 10436 号】通知,公司股东梁国豪先生持有的 917,280 股 公司股份将被司法拍卖;根据淘宝网司法拍卖网络平台显示的拍卖结果,前述 司法拍卖因无人出价已流拍。具体内容详见公司于 2025 年 8 月 21 日及 ...
信濠光电11月11日获融资买入394.27万元,融资余额9264.94万元
Xin Lang Cai Jing· 2025-11-12 01:28
Core Insights - On November 11, Xinhau Optoelectronics experienced a decline of 0.90% in stock price, with a trading volume of 46.51 million yuan [1] - The company reported a financing buy-in of 3.94 million yuan and a financing repayment of 5.36 million yuan, resulting in a net financing outflow of 1.41 million yuan [1] - As of November 11, the total margin balance for Xinhau Optoelectronics was 92.65 million yuan, which accounts for 2.07% of its market capitalization, indicating a low financing balance compared to the past year [1] Financing and Margin Data - On the same day, the financing buy-in was 3.94 million yuan, while the financing balance stood at 92.65 million yuan, below the 10th percentile level of the past year [1] - In terms of securities lending, there were no shares repaid or sold on November 11, with the securities lending balance also at zero, indicating a high level compared to the 90th percentile of the past year [1] Company Overview - Xinhau Optoelectronics, established on November 26, 2013, and listed on August 27, 2021, is located in Dongguan, Guangdong Province [1] - The company's main business involves the research, production, and sales of glass protective screens, with revenue composition as follows: 81.07% from smartphones and computers, 7.60% from smart headsets and wearables, and 6.79% from other smart terminals [1] Financial Performance - For the period from January to September 2025, Xinhau Optoelectronics achieved a revenue of 1.306 billion yuan, representing a year-on-year growth of 5.79% [2] - The company reported a net profit attributable to shareholders of -87.99 million yuan, which is a significant year-on-year increase of 57.43% [2] Dividend Information - Since its A-share listing, Xinhau Optoelectronics has distributed a total of 112 million yuan in dividends, with 32.46 million yuan distributed over the past three years [3]
信濠光电(301051.SZ):有产品间接应用于华为相关产品,暂未应用于华为Mate系列
Ge Long Hui· 2025-11-11 08:00
Core Viewpoint - The company has products that are indirectly applied in Huawei-related products, but they are not yet used in the Huawei Mate series [1] Group 1 - The company is committed to maintaining close cooperation with mainstream brands in the consumer electronics industry [1] - The company has established a strong competitive advantage in relevant niche areas [1]